期刊文献+

高通量透析对血透患者中分子毒素及左心室结构的影响 被引量:1

Effect of High Flux Hemodialysis on Middle Molecular Weight Toxins and Left Ventricular Structure
下载PDF
导出
摘要 目的:探讨高通量透析对血液透析患者中分子毒素及左心室结构的影响。方法:选取本院尿毒症维持性血液透析(MHD)患者40例,随机分为高通量透析(HFD)组和常规通量透析(CHD)组,每组各20例,检查患者的血红蛋白(HGB)、血肌酐(Cr)、尿素氮(BUN)、血清白蛋白(ALB)、血磷(P)、血钙(Ca)、β2-微球蛋白(β2-MG)、甲状旁腺激素(i PTH)、超敏C-反应蛋白(CRP)、甘油三酯(TG)、总胆固醇(CHOL)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)指标;心脏超声检测心脏左室收缩末期内径(LVESD)、左室舒张末期内径(LVEDD)、左室射血分数(EF值)、左心室后壁厚度(LVPWT)、室间隔厚度(IVST)、左房内径(LAD),分别对比0、6、12个月以上指标的改善情况。结果:HFD组6、12个月血β2-MG、i PTH水平较0个月明显降低,比较差异有统计学意义(P<0.05),HFD组6、12个月血CRP、ALB较0个月有所好转,比较差异有统计学意义(P<0.05),而CHD组各个指标6、12个月与0个月比较差异无统计学意义(P>0.05);HFD组6、12个月心超指标LVESD、LVEDD、EF值、IVST、LVPWT较0个月有所改善,比较差异均有统计学意义(P<0.05),而CHD组心超各个指标6、12个月较0个月均无统计学差异(P>0.05)。结论:HFD较CHD组能更有效地降低MHD患者中分子毒素水平,并且能更有效改善MHD患者的左室结构和功能。 Objective: To investigate the effect of high flux hemodiafihration ( HFD ) on middle molecular weight toxins and left ventricular structure of maintenance hemodialysis patients of uremia.Method: 40 MHD patients were randomly divided into the HFD group and the CHD ( conventional hemodialysis ) group, 20 cases in each group.the blood samples of HGB, Cr, BUN, ALB, P, Ca, 13 2-MG, iPTH, CRP, TG, CHOL, HDL, LDL, the left ventricular structure and function parameters ( LVESD, LVEDD, EF, LVPWT, LVST and LAD ) by echocardiogram at 0, 6, 12 months were detected.Result: The level of serum 13 2-mieorglobulin, iPTH were significantly decreased after treatment for 6 months and 12 months in HFD group ( P〈0.05 ), the level of CRP and ALB were significantly improved after treatment for 6 months and 12 monthsin HFD group ( P〈0.05 ) . All of the blood samples were not improved after treatment for 6 months and 12 months in CHD group ( P〉0.05 ), the left ventricular structure and function parameters ( LVESD, LVEDD, EF, LVPWT, IVST ) were improved after treatment for 6 months and 12 months in HFD group ( P〈0.05 ), but not improved in CHD group ( P〉0.05 ) . Conclusion: Comparing with CHD, HFD can significantly clear the middle molecular weight toxins of maintenance hemodialysis patients of uremia, and improve the left ventricular structure and function.
出处 《中国医学创新》 CAS 2016年第8期53-56,共4页 Medical Innovation of China
基金 杭州市科技局课题(124772)
关键词 高通量透析 中分子毒素 左心室结构 High-flux hemodialysis Middle molecular weight toxins Left ventricular structure
  • 相关文献

参考文献9

  • 1Duran M,Unal A,Inanc M T,et al.Hemodialysis does not impair ventricular functions over 2 years.Hemodialysis International,2011,15(3):334-340. 被引量:1
  • 2王质刚.血液净化学[M].3版.北京:北京科学技术出版社,2009:883. 被引量:5
  • 3John F,Jürgn F,Richard J J.Comprehensive clinical nephrology[M].3rd edition.Philadelphia:Mosby,2007:839-853. 被引量:1
  • 4季大玺.高通量血液透析的可能益处[J].中国血液净化,2005,4(7):349-351. 被引量:76
  • 5Dember L M,Jaber B L.Dialysis-related amyloidosis:late finding or hidden epidemic[J].Seminars in Dialysis,2006,19(2):105-109. 被引量:1
  • 6Cheung A K,Rocco M V,Yan G,et al.Serumβ2-microglobulinlevels predict mortality in dialysis patients:results ofthe HEMO study[J].J Am Soc Nephrol,2006,17(2):546-555. 被引量:1
  • 7Okuno S,Ishimura E K,Fujino-katoh Y,et al.Serumβ2-microglobulinlevel is a significant predictor of mortality in maintenance haemodialysis patients[J].Nephrol Dial Transplant,2009,24(2):571-577. 被引量:1
  • 8William F,Owen Jr,Brian J,et al.Dialysis and transplantation.Inded[M].Science Press,2001:224. 被引量:1
  • 9黄志勇,钟家浩,卓建钦.高通量血液透析联合超纯透析液对尿毒症贫血的影响[J].中国医学创新,2011,8(21):51-52. 被引量:5

二级参考文献29

  • 1龚德华,季大玺,谢红浪.高通量透析器复用的研究[J].医学研究生学报,2000,13(5):307-310. 被引量:26
  • 2唐万欣,付平,杨宁,周莉,黄颂敏,许国章.高通量透析联合大剂量促红细胞生成素治疗尿毒症贫血的临床观察[J].新医学,2006,37(2):81-83. 被引量:11
  • 3Ledebo I, Nystrand R. Defining the microbiologicaI quality of dialysis fluid. Artif Organs, 1999,23:37 - 43. 被引量:1
  • 4Jacobs C, Kjellstrand CM, Koch KM, et al. Keplacement of renal function by dialysis. 4th Revised Edition, Mrtherland:Lluwer Academic publisher, 1996,432 被引量:1
  • 5Ley poldt JK, Cheung AK, Clark WR,et al. Characteriza tion of low and high-flux dialyzers NIH HEMO study:Interim report(Abstract). J Am Soc Nephrol,1996,7:1518 被引量:1
  • 6K linkmann H, Vienken J. Membranes of dialysis, Nephrol Dia Transplant, 1995,(10)S3:39 被引量:1
  • 7Leto E, Bilal F, Osmic I. Efficiency of high-flux dialysis in removal of beta-mcroglobulin. Med Ash, 2001, 55(4):225 被引量:1
  • 8Schiffl H, Fischer R, Lang SM, et al. cliniCal manifes tations of AB-anyloidosis:effeets of biocompatibility and flux. Nephrol Dia Transplant, 2000,15:840 被引量:1
  • 9Kucharska E, Stompor T, Salowicz W, et al. Kenal osteodystrophy in dialysis patients as estimated by three-point bone densitometry. Prezgl Lek, 2000, 57(6):334 被引量:1
  • 10Lugon JR, Andre ME, Duarte ME, et al. Effects of in center daily hemodialysis upon mineral metabolism and bone disease in and stage renal disease patients. Sao Paulo Med J, 2001,119(3):105 被引量:1

共引文献81

同被引文献12

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部